THE DOSE ANALYSIS OF BORON NEUTRON CAPTURE THERAPY (BNCT) TO THE BRAIN CANCER (GLIOBLASTOMA MULTIFORM) USING MCNPX-CODE WITH NEUTRON SOURCE FROM COLLIMATED THERMAL COLUMN KARTINI RESEARCH NUCLEAR by Hasyim, Kholidah et al.
95  
 
THE DOSE ANALYSIS OF BORON NEUTRON CAPTURE THERAPY (BNCT) TO THE 
BRAIN CANCER (GLIOBLASTOMA MULTIFORM) USING MCNPX-CODE WITH 
NEUTRON SOURCE FROM COLLIMATED THERMAL COLUMN KARTINI 
RESEARCH NUCLEAR 
Kholidah Hasyim NM1, Y. Sardjono2, Yosaphat Sumardi1 
 
1Physics Department, Mathematics and Natural Science Faculty, Yogyakarta State University, 
Karangmalang, Yogyakarta 
2Center of Accelerator and Material Process Technology – BATAN 
Email: yudhakholidha@gmail.com 
 
Abstract This research was aimed at discovering the optimum concentration of Boron-10 in concentrations range 20 
µgram/gram until 35 µgram/gram with Boron Neutron Capture Therapy (BNCT) methods and the shortest time 
irradiation for cancer therapy. The research about dose analysis of Boron Neutron Capture Therapy (BNCT) to the 
brain cancer (Glioblastoma Multiform) using MCNPX-Code with a neutron source from Collimated Thermal Column 
Kartini Research Nuclear has been conducted. This research was a simulation-based experiment using MCNPX, and 
the data was arranged on a graph using OriginPro 8. The modelling was performed with the brain that contains cancer 
tissue as a target and the reactor as a radiation source. The variations of Boron concentrations in this research was on 
20, 25, 30 and 35 μg/gram tumours. The outputs of MCNP were neutron scattering dose, gamma ray dose and neutron 
flux from the reactor. Neutron flux was used to calculate the doses of alpha, proton and gamma rays produced by the 
interaction of tissue material and thermal neutrons. Based on the calculations, the optimum concentration of Boron-10 
in tumour tissue was for a 30 µg/gram tumour with the radiation dose in skin at less than 3 Gy. The irradiation times 
required were 2.79 hours for concentration 20 μg/gram ; 2.78 hours for concentration 25 μg/gram ; 2.77 hours for 
concentration 30 μg/gram ; 2.8 hours for concentration 35 μg/gram. 
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INTRODUCTION 
   Cancer is the disease which gets 
special attention because of its lethal and 
benign characteristics (American Cancer 
Society, 2014). Some treatment methods for 
cancer are radiotherapy, surgery and 
chemotherapy. The surgery method is that of 
taking cancer out of the human body. This 
method is usually used for the first stage of 
cancer where the cancer is benign and it does 
not spread to another of the body’s tissues 
(Cember, Johnson, & Alaei, 2009; Sudhakar, 
2009). Chemotherapy methods can be 
combined with surgery, utilizing drugs to kill 
the cancerous tissue (Cember et al., 2009). 
The new technology of radiotherapy 
that may be used for cancer treatment is Boron 
Neutron Capture Therapy (BNCT).  BNCT is 
a cancer therapy technique that uses the 
physics principles of nuclear reactions which 
occur when Boron-10 is irradiated by low 
energy neutrons (thermal neutrons). This 
reaction between boron and thermal neutrons 
produces Boron-11 (t1/2=10
-23second). Boron-
11m decays by emitting alpha particle, 
Lithium-7 particle and gamma ray. In BNCT, 
Boron-10 and its carrier drug are administered 
to the patient. This carrier will take the 
compound to the location of the cancer tissue 
where Boron-10 needs to be accumulated. 
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Then the cancer area is irradiated by neutron 
source (Bakirdere, Orenay, & Korkmaz, 2010). 
Boron-10 in the cancer tissue will capture the 
thermal neutron resulting from a prompt 
nuclear reaction Boron-10(n,α)Lithium-7. 
Both γ-particle and Lithium-7 have relatively 
high Linear Energy Transfer (LET) values 
(175 keVmn and above) and short path lengths 
(approximately 4.5 to 10 µm), hence the 
energy deposition is locally limited around the 
cancer tissue (W. Sauerwein, 1993). 
       Lithium has a dose limit in the human 
body amounting to 900-1800 mg/day or 1.5-
2.5 meQ/L. Lithium concentrations exceeding 
3.5 meQ/L are fatal for humans. The ratio of 
Boron-10 concentrations in cancer tissue and 
health tissue was 10:1 so that the research is 
selective because the neutron reaction 
probability with Boron-10 is greater in cancer 
tissue(W. A. G. Sauerwein & Moss, 2009). 
 
MATERIAL AND METHODS 
       This study was a simulation-based 
experiment using MCNPX. In the first step, it 
was necessary to make a model of the reactor 
since it would be used as the neutron source. 
Several parts of the reactor were modelled, 
such as core, the radial reflector, rotary 
specimen rack, and piercing beam port. The 
thermal column was also built since it would 
become the point of interest. Simulation was 
done to make sure that the criticality value was 
approximately 1, and the thermal neutron flux 
in the ring B was approximately (12.45 ± 0.23) 
x 1011n.𝑐𝑚−2. 𝑠−1 (Fauziah Nina, Widiharto, 
& Sardjono, 2015). The result should be 
recorded for the next collimator conceptual 
design process. In an MCNP input file, tallies 
are the information that a user wants to obtain 
by Monte Carlo calculation. According to the 
beam criteria in Table 1, the tallies were 
needed for resulting fluxes and current data. 
Neutron and gamma fluxes were calculated by 
using F4 tally and corresponding dose values 
were determined using fluence to kerma 
conversion factors reported in ICRU 63. 
Moreover, neutron current was calculated 
using F1 tally. Normalization factors for each 
tally were calculated for normalizing the tallies 
reactor within 100 kW thermal power.  
       Secondly, the collimator was designed. A 
rough collimator design was made by using 
MCNPX codes: 95 cm length of collimator, 54 
cm of outer collimator diameter, 3 cm thick of 
beam delimiter, and 3 cm sized aperture. The 
beam delimiter was made of 6Li2CO3-
polyethylene. In designing the collimator, one 
should start with the varied sizes of the 
collimator wall. The material used was Ni. The 
best thickness would be that which provided 
the highest epithermal neutron flux. Then, 
moderator, Al, was varied until the fast neutron 
component decrease was no longer significant. 
In this point, 𝑁𝑖60  , which served as a fast 
neutron absorber, also absorbed the thermal 
neutrons, and started to be used and varied until 
the fast and thermal neutron components were 
reached.  
      The next step was to employ Bi as gamma-
ray shielding into the collimator and alter its 
thickness until the desired gamma-ray 
component was gained. The last parameter of 
beam quality was the examination of the 
direction of the collimator. If the direction of 
the collimator was less than desired, more 
beam delimiter would be added. The last step 
conducted was setting the aperture or the beam 
cross section size to find out the performance 
of the collimator design. 
       The modelling of brain geometry was 
ellipsoid with diameters x axis was 21.2 cm.  
The cancer location in a lobus frontalis with 
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3.3 cm of deepness from skin surface. In this 
simulation, we used a 0.6 cm thickness of 
scalp, a 0.6 cm thickness of cranium, a 0.6 cm 
thickness of cranium, a16.7 cm thickness of 
soft tissue, a 0.3 cm thickness of Planning 
Tumor Volume (PTV), a 0.5 cm thickness of 
Clinical Tumor Volume (CTV), and a 4 cm 
diameter of Gross Tumor Volume (GTV) or 
cancer). 
 
RESULT AND DISCUSSION 
       Thermal neutron source was produced by 
the model of Collimated Thermal Column 
Kartini Research Nuclear Reactor. The neutron 
criteria of thermal column outputs was shown 
at Table 1 (IAEA, 2014). 
 
Table 1. Neutron criteria of collimated thermal column 
outputs. 
Parameter Values 
𝜙𝑒𝑝𝑖(𝑛. 𝑐𝑚
−2. 𝑠−1) 1.65 x 10 9 
𝐷?̇?/ 𝜙𝑒𝑝𝑖(𝐺𝑦. 𝑐𝑚
2. 𝑛−1) 1.59 x 10-13 
𝐷?̇?/ 𝜙𝑒𝑝𝑖(𝐺𝑦. 𝑐𝑚
2. 𝑛−1) 1.16 x 10-13 
𝜙𝑡ℎ/𝜙𝑒𝑝𝑖 0.007 
𝐽/𝜙𝑒𝑝𝑖 0.72 
 
Table 2.  The outputs of collimated thermal column. 
Cell Name Termal Flux 
(n.𝑐𝑚−3.𝑠−1) 
Epiermal Flux (n.𝑐𝑚−3.𝑠−1) Fast Neutron 
(n.𝑐𝑚−3.𝑠−1) 
134 Before reached skin 2.011 
E+08 
1.161 
E+09 
5.53E+07 
8 scalp 9.557 
E+07 
8.909 
E+07 
5.10E+05 
9 cranium 6.670 
E+07 
5.854 
E+07 
0.00E+00 
10 soft tissue 1.386 
E+07 
1.808 
E+07 
0.00E+00 
11 cerebrum 6.652 
E+07 
1.993 
E+08 
0.00E+00 
12 PTV 2.30 
3E+06 
9.511 
E+06 
0.00E+00 
13 CTV 6.217 
E+05 
3.848 
E+06 
0.00E+00 
14 GTV 1.374 
E+05 
7.265 
E+05 
0.00E+00 
17 slice 5.021 3.094 0.00E+00 
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E+07 E+07 
18 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
19 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
20 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
21 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
24 slice 0.000E+00 0.000E+00 0.00E+00 
25 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
26 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
27 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
28 slice 0.000E+00 0.000E+00 0.00E+00 
29 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
30 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
31 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
32 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
33 slice 0.000 
E+00 
0.000 
E+00 
0.00E+00 
 
 
      Table 2 shows flux of boron concentration 
35 µgram/gram. The others, (20 µgram/gram, 
25 µgram/gram and 30 µgram/gram) have 
characteristics and values that nearly match 
those of table 2.  
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Fig 1. Forms of neutron flux 
       Figure 1 shows three form of fluxes. These 
are thermal flux, epithermal flux and fast 
neutron. When a boron concentration was 
injected at 35 µgram/gram cancer, epithermal 
flux on the skin surface was 1,61E+09 
n.𝑐𝑚−2.𝑠−1. Thermal flux was 2,011+08 
n.𝑐𝑚−2.𝑠−1. 
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Fig 2.  Total Absorption Dose 
 
        Total absorption dose is a multiplication 
of dose rate and time irradiation where time 
irradiation was obtained from minimal dose 
destroyer of cancer (on Gy). The minimal dose 
limit that was used on this simulation was 30 
Gy. The time irradiation can be seen on table 
3. 
Table 3. Dose rate and time irradiation on the cancer 
tissue. 
Boron 
concentr
a-tion 
Total 
Dose 
(Gy/ 
second) 
Time 
irradiatio
n for 30 
Gy 
(second) 
Time 
irradiatio
n for 30 
Gy 
(minute) 
20 
µg/gram 
cancer 
0.00029
9 
10029,48 167,16 
25 
µg/gram 
cancer 
0.0003 100000,3
9 
166,67 
30 
µg/gram 
cancer 
0.00030
1 
9956,24 165,94 
35 
µg/gram 
cancer 
0.00029
8 
10071,26 167,85 
 
       In Table 3, the time needed for irradiation 
can be seen. The irradiation time needed on the 
boron concentration at 30 µg/gram cancer was 
shortest. Table 4 shows the deterministic effect 
on skin. Deterministic effect can be known 
based on the optimum dose that can be 
absorbed by tissues. 
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Table 4. Deteriministic effect on skin (Bapeten, 2015). 
Radiation effect Dose 
range 
(Gy) 
Time 
Beginning eritema 2-3 6-24 
hours 
Epilasi and dry 
deskuamasion 
3-12 3-6 weeks 
Wet Deskuamasi 12-20 4-6 weeks 
Nekrosion >20 10 weeks 
 
Table 5. The estimated deteriministic effect on the skin 
Boron 
Concentration 
Range dose 
absorbed on 
skin(Gy) 
Estimated 
effect that 
accepted 
20 µg/gram 
cancer 
0.99 -- 
25 µg/gram 
cancer 
0 -- 
30 µg/gram 
cancer 
-- -- 
35 µg/gram 
cancer 
2.93 Beginning 
eritema 
 
       Table 5 shows that in the concentrations of 
20 µg/gram, 25 µg/gram and 30 µg/gram 
cancer no effect was made on skin. Boron 
concentration 35 µg/gram cancer gives the 
deteriministic effect of beginning eritema. 
Eritema is a redness skin phenomenon because 
of capillary artery widening that cause the 
highest radiation exposure(Setiyadi, Sardjono, 
& Darmawan, 2016; Young & Kerr, 2002).  
 
CONCLUSION 
       Based on the calculations, with the 
optimum concentration of Boron-10 in tumour 
tissue was 30 µg/gram tumour the radiation 
dose in the skin was less than 3 Gy. The 
optimum irradiation times was 2.79 hours for 
concentration 20 μg/gram; 2.78 hours for 
concentration 25 μg/gram; 2.77 hours for 
concentration 30 μg/gram; 2.,8 hours for 
concentration 35 μg/gram. 
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